CGRP抑制了CD4+ T细胞的反应和过敏敏感化
Xiaoshi Li1, Ying Zhang1, Wenlong Chen1
1Department of Biochemistry, SUSTech Homeostatic Medicine Institute, University Laboratory of Metabolism and Health of Guangdong, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Frontiers in immunology
|December 31, 2025
概括
素基因相关 (CGRP) 和受体活性修饰蛋白1 (RAMP1) 途径抑制CD4+ T细胞激活,抑制过敏敏感化. 通过调节T细胞反应,CGRP治疗可缓解过敏性喘.
科学领域:
- 神经免疫学 神经免疫学
- 过敏和免疫学 过敏和免疫学
背景情况:
- 素基因相关 (CGRP) 是一种参与免疫调节的神经,但其在适应性免疫中的作用尚不清楚.
- 确定CGRP-RAMP1通路是过敏敏感化期间CD4+T细胞反应的关键内在调节器.
研究的目的:
- 研究CGRP-RAMP1通路在过敏敏感化期间调节CD4+T细胞反应中的作用.
- 确定CGRP在减轻过敏性喘方面的治疗潜力.
主要方法:
- 在小鼠中使用室内灰尘虫 (HDM) 诱导过敏敏感化.
- 对CGRP+感觉神经纤维分布和RAMP1表达在免疫细胞上的分析.
- 采用TCR-seq,Parabiosis,采用转移,流细胞计,ATAC-seq和RNA-seq等技术来研究CD4+T细胞功能.
- 在HDM诱导的过敏喘模型中使用CD4+T细胞特异的RAMP1淘汰小鼠和CGRP治疗.
主要成果:
- CGRP-RAMP1信号抑制CD4+T细胞激活和分化,并抑制Tfh相关基因表达.
- 在过敏敏感化期间,淋巴结中的CGRP+纤维密度降低.
- 特定于CD4+T细胞的RAMP1缺乏症通过促进Tfh细胞积累而加剧过敏敏感性.
- 外源性CGRP治疗减轻了过敏敏感性,并以RAMP1依赖的方式缓解过敏喘.
结论:
- CGRP-RAMP1通路充当神经免疫轴,通过直接调节CD4+T细胞免疫生物学来抑制过敏敏感化.
- 通过向这种神经免疫通路,CGRP治疗显示出对过敏性喘的治疗潜力.
更多相关视频
相关概念视频
01:09GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
01:12GPCR Desensitization
7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
02:06Allergic Reactions
31.9K
Overview
31.9K
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
01:20Desensitization and Tachyphylaxis
2.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K